|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||74.85 - 74.85|
|52-week range||74.85 - 74.85|
|Beta (5Y monthly)||0.37|
|PE ratio (TTM)||27.03|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
CVS acquiring Oak Street and Amazon acquiring One Medical are just the latest moves in retail health. But they could have significant future impact.
Seagen is once again an acquisition target this year, pursued by yet another partner, Pfizer. Last year, a deal with Merck fell through over price disagreements.
Merck, Thermo Fisher Scientific, American Express, Valero Energy and Weyerhaeuser are part of the Zacks top Analyst Blog.